Spatial bayesian modeling of diabetes mellitus (DM) risk in the United States

美国糖尿病风险的空间贝叶斯建模

阅读:1

Abstract

BACKGROUND: Spatial targeting of disease burden has long been instrumental to achieving optimal health resource allocation in the United States (US). Building on a previous study, the current research examined the spatial variation and hotspots of Diabetes Mellitus (DM) risk across the US. METHODS: The outcome variable was the number of DM cases per county acquired from the CDC-Behavioral Risk Factor Surveillance System (BRFSS). Air pollution data (PM(2.5) & NO(2)) were acquired from the Socioeconomic Data and Application Centre (SEDAC), obesity cases from the BRFSS, and maximum temperature data from WorldClim. The percentage of alcoholics and smokers was obtained from the County Health Rankings & Roadmaps Association. We model the spatial pattern of DM risks by coupling the integrated nested Laplace approximation (INLA) and the Local Indicator of Spatial Autocorrelation (LISA). RESULTS: The spatial distribution of diabetes mellitus (DM) risk was non-random (I = 0.428; p < 0.001). The elevated risk was concentrated in the US South, where multiple counties were classified within the highest standard deviation band, at or above 2.5 standard deviations above the national expected risk (RR = 1). After adjusting for spatial confounding, smoking increased the risk of DM by 8.3% (RR = 1.083, 95% CI: 1.07, 1.095), and obesity also increased DM risk by 0.7% (RR = 1.007; 95% CI: 1.000, 1.014). However, maximum temperature (RR = 0.998; 95% CI: 0.982, 1.013), NO(2) concentration (RR = 0.996; 95% CI: 0.984, 1.008), Social Vulnerability Index (RR = 0.99; 95% CI: 0.98, 1.001), and PM(2.5) concentration (RR = 0.993; 95% CI: 0.97, 1.017) were not statistically significantly related to DM risk. CONCLUSION: The US South was found to be the region most at risk for the DM burden. Unlike previous research, our study also identified Florida and Maine as areas requiring equal attention. Although cross-sectional, the findings from this study provide essential information for targeted public health interventions. CLINICAL TRIAL NUMBER: Not applicable.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。